The medical second opinion market is expected to more than triple in value over the next five years, with orthopedic second opinions seeing the highest growth, according to a report from the Insight Partners.
In 2019, the overall global second opinion market was valued at $3.2 billion, but by 2027 it is estimated to be valued at $10.73 billion, the research company said in a July 11 press release.
While second opinions are becoming increasingly popular across the entire medical field, orthopedic disorder diagnoses lead the charge.
The second opinion market will also grow for cancer, cardiac disorders, neurological disorders, blood disorders, organ transplants and pulmonary disease, according to the press release.
Though hospitals saw the largest growth in second-opinion seeking in 2019, it is expected that online services will see the largest growth going forward.
In 2019, North America had the largest share of the second opinions market.
While the market is growing globally, individuals in emerging nations are reluctant to seek medical second opinions, restraining the market's growth, the press release said.